Skip to main content
MEDP
NASDAQ Industrial Applications And Services

Medpace Shareholders Approve Major Governance Changes, Empowering Shareholder Action

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$423.59
Mkt Cap
$12.098B
52W Low
$287.17
52W High
$628.916
52W Position info
48% above low
Off High info
33% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MEDP sits 48% above its 52-week low of $287.17.

Summary

Medpace shareholders approved key governance changes, eliminating supermajority voting and granting a 25% shareholder group the right to call special meetings, enhancing investor influence.


Key Events · Corporate Governance and Compliance · MEDP

  • Supermajority Voting Removed

    Stockholders approved an amendment to remove supermajority voting requirements from the Certificate of Incorporation, making it easier for a simple majority to pass resolutions.

  • Shareholders Can Call Special Meetings

    Stockholders approved an amendment granting a group owning at least 25% of the voting power (with one year of continuous ownership) the right to call special meetings.

  • Bylaw Amendments Adopted

    The Board approved conforming amendments to the Bylaws to reflect the new ability for stockholders to call special meetings, detailing the requirements and limitations.

  • Annual Meeting Results

    All director nominees were elected, the appointment of Deloitte & Touche LLP as the independent auditor was ratified, and executive compensation was approved on an advisory basis.


Analysis · MEDP · Industrial Applications And Services

Shareholders of Medpace Holdings, Inc. have approved significant amendments to the company's corporate governance structure. These changes remove supermajority voting requirements, making it easier for a simple majority of shareholders to pass resolutions. Additionally, stockholders now have the right to call special meetings, provided a group owns at least 25% of the voting power for one year. These changes enhance shareholder influence and oversight, which is particularly relevant given the recent securities fraud class action lawsuit filed against the company.

How filings like this one have moved

In the 30 days to Nov 8, 2026, 46.6% of the 1552 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.23%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MEDP was trading at $423.59 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $12.1B. The 52-week trading range was $287.17 to $628.92. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEDP - Latest Insights

MEDP
Oct 22, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $653.96
Real-time Price: $653.11 info
Change: -$0.850 (-0.13%) info
Market Cap: $18.269B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $635.00
Real-time Price: $653.11 info
Change: +$18.11 (+3%) info
Market Cap: $18.269B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $661.00
Real-time Price: $653.11 info
Change: -$7.89 (-1%) info
Market Cap: $18.269B info
MEDP
Sep 28, 2026, 7:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $615.94
Real-time Price: $653.11 info
Change: +$37.17 (+6%) info
Market Cap: $18.269B info
MEDP
Jul 27, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $589.37
Real-time Price: $653.11 info
Change: +$63.74 (+11%) info
Market Cap: $18.269B info